Bruker Corp is primarily active in the life sciences and analytical research industries.

The main competitors of Bruker Corp in the market include Agilent Technologies, Thermo Fisher Scientific, and Shimadzu Corporation.

Bruker Corp is a renowned scientific instruments and solutions provider, headquartered in Billerica, Massachusetts. Founded in 1960 by Dr. Günther Laukien, the company has a rich history of innovative developments in analytical and diagnostic equipment. Bruker Corp initially focused on the design and manufacture of NMR spectroscopy systems and quickly gained recognition for its cutting-edge technology. Over the years, the company expanded its product portfolio to include technologies for life sciences, materials research, clinical research, and more. Bruker Corp has a global presence, serving a diverse range of industries, including pharmaceuticals, biotechnology, academia, and government institutions. It continues to be a leading player in the scientific instrumentation field with a commitment to advancing research and enabling scientific discovery.

Bruker Corp has achieved several significant milestones throughout its history. One notable accomplishment is the company's successful expansion into various analytical and diagnostic technologies. Bruker Corp has also made significant advancements in the field of scientific research, particularly in the areas of life sciences, materials research, and industrial applications. Moreover, the company has consistently strived to innovate and develop cutting-edge solutions that cater to its customers' diverse needs. Bruker Corp's commitment to excellence and its focus on delivering high-quality products and services have contributed to its industry-leading position and continued growth.

Bruker Corp is primarily present in various countries and regions around the world. These include the United States, Germany, China, Japan, India, France, the United Kingdom, and many others. With a global presence, Bruker Corp caters to a wide range of customers and markets its innovative analytical instruments and solutions internationally.

Bruker Corp represents values of innovation, collaboration, and excellence. As a leading provider of scientific instruments and solutions, Bruker Corp is committed to delivering cutting-edge technology to enable advancements in research and analysis. Their corporate philosophy revolves around customer-centricity, striving to understand the unique needs of their clients and providing tailored solutions to meet their requirements. With a focus on quality, Bruker Corp emphasizes continuous improvement and rigorous standards in their products and services. By fostering strategic partnerships and fostering a culture of continuous learning, Bruker Corp aims to drive scientific discovery and empower researchers worldwide.

Analysts currently set an average price target of 55,03 USD for the Bruker stock (median: 56,10 USD), implying +3,0 % versus the latest price. The consensus is based on 22 analyst ratings.

Bruker Analyytikkojen kursstavoitteet 2026

22 analysts currently rate the Bruker stock: 15 recommend buying, 6 holding and 1 selling. For 2026, analysts expect Bruker to generate revenue of 3,59 Mrd. USD and earnings per share of 2,11 USD.

Bruker Analyytikkojen kursstavoitteet 2026

Converted at the current exchange rate, the Bruker share trades at 46,23 EUR (53,41 USD).

The Bruker share (BRKR) is listed on 3 stock exchanges, including: NASDAQ (BRKR), Frankfurt (BKD.F), SIX (Zürich) (BKD.SW).

The Bruker Corporation is a company for scientific instruments and solutions, focusing on analytical and diagnostic instruments for applications in biology, chemistry, and physics. The company was founded in 1960 and has its headquarters in Billerica, Massachusetts. Bruker's business activities are divided into four different segments: 1. Scientific Instruments This segment is the main revenue driver for Bruker and focuses on the development, manufacturing, and marketing of scientific instruments and solutions for research, diagnostic, and analytical applications in a variety of industries. For example, analytical instruments for the pharmaceutical industry, cosmetics industry, food industry, environmental monitoring, and materials science are offered here. The product range includes spectroscopy systems, mass spectrometry, NMR spectroscopy, X-ray analysis, optical emission spectroscopy, and microscopy. 2. Energy & Supercon Technologies This segment offers a wide range of products and solutions for the energy industry as well as for research and development in the field of superconductivity. Bruker is a major provider of analysis, measurement, control, and monitoring systems for the power and gas supply infrastructure, as well as for the development of materials for energy generation and transmission. The solutions offered include spectroscopy systems, analytical sensors, magnetic resonance imaging systems, and superconducting magnets. 3. Nanoscience & Advanced Materials This segment is dedicated to the research, development, and production of devices and systems for the analysis and application of nanomaterials and structures, as well as for new materials such as polymers, ceramics, and metals. The products included in the program range from atomic force microscopes to analytical electron microscopes and X-ray diffractometers to software for modeling and simulating materials. 4. Bruker Scientific Services This segment offers a variety of services for all the aforementioned attribute areas, providing customers with useful services such as repairs, technical support, and training. In addition, the company also offers maintenance contracts, calibrations, upgrades, and spare parts for its instruments and systems. In summary, Bruker offers a wide portfolio of products and solutions for science and industry. Bruker's business model is focused on providing professional and technologically advanced products and services for research institutions, laboratories, and companies.

odotettu liikevaihto Bruker on 3,59 Mrd. USD. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.

odotettu voitto Bruker on 321,88 M USD. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.

Bruker:n hinta-voitto-suhde (P/E) on tällä hetkellä 25,30. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Bruker-osakkeen arvostusta.

Bruker:n hinta-myynti-suhde (P/S) on tällä hetkellä 2,27. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Bruker-osakkeen arvostuskennuslukuna.

Bruker:n Eulpool-laatuscore on 3/10.

Bruker:n ISIN on US1167941087. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.

Bruker:n WKN on 813534. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.

Bruker:n ticker on BRKR. Tämä pörssinoteeraus käytetään Bruker-osakkeiden kauppaan pörssissä.

Viimeisten 12 kuukauden aikana Bruker maksoi osinkoa 0,20 USD . Tämä vastaa osingontuottoa noin 0,37 %. Tulevien 12 kuukauden aikana Bruker odotetaan maksavan osinkoa 0,21 USD.

Bruker:n nykyinen osinkotuotto on 0,37 %.

Bruker maksaa osinkoa, joka jaetaan kuukausina , , , .

Bruker maksoi osinkoa joka vuosi viimeisten 10 vuoden aikana.

Tulevien 12 kuukauden aikana odotetaan osinkoja, joiden määrä on 0,21 USD. Tämä vastaa osingontuottoa 0,39 %.

Bruker kuuluu sektoriin 'Terveydenhuolto'.

Saadaksesi viimeisen osingon Bruker:sta päivältä määrässä 0,05 USD, sinulla piti olla osake portfoliossasi ennen irtoamispäivää .

Viimeinen osinko maksettiin .

Vuonna 2025 Bruker jakoi 0,2 USD osinkona.

Bruker:n osingot jaetaan valuutassa USD.